Last updated: October 9, 2025
Introduction
Israel patent IL186555 pertains to a pharmaceutical invention, with implications for the landscape of medicinal patents within Israel and potentially beyond. Understanding its scope and claims is essential for stakeholders—including pharmaceutical companies, generic manufacturers, and patent attorneys—to navigate litigation, licensing, and R&D strategies effectively. This analysis elucidates the scope of IL186555, its claims structure, and its position within the patent landscape.
Patent Overview
Israel patent IL186555 was granted to a pharmaceutical entity (details on the applicant are typically available through the Israel Patent Office database) and is categorized under the pharmacological inventions domain. The patent aims to protect a specific formulation, compound, or therapeutic method, with enforceability extending typically 20 years from the earliest filing date, subject to maintenance fees.
Claim Structure and Scope
1. Independent Claims
The core of IL186555 comprises independent claims that define the broadest scope of the invention. These claims generally stipulate the structure of a pharmaceutical compound or a method of treatment.
-
Chemical Composition Claims:
These claims specify the molecular structure, defining the core compound, possibly including salt forms, isomers, or prodrugs.
Example: a claim might cover a novel derivative of a known drug compound.
-
Method of Use Claims:
Claims in this category detail specific therapeutic uses, such as treating a particular disease or condition with the compound.
-
Formulation Claims:
These cover specific formulations, including delivery methods or carriers that enhance bioavailability or stability.
2. Dependent Claims
Dependent claims narrow the scope, adding specific limitations to the independent claims, such as particular dosages, combinations with other agents, or specific manufacturing processes. This layered approach strengthens the patent’s defensibility by covering various embodiments.
3. Claim Interpretation
The claims’ interpretation determines patent infringement scope. Israeli courts generally interpret claims in accordance with the language’s plain meaning, supplemented by the patent description. The patent’s description provides contextual background, emphasizing novelty and inventive step over prior art.
Scope of Patent IL186555
The scope of IL186555 appears focused on identifying a novel compound or therapeutic method with a clear inventive step over existing treatments. The core claims likely encompass:
- A chemically novel compound with specific structural features.
- A therapeutic application of said compound for particular indications.
- Formulations or delivery systems enhancing efficacy.
In pharmaceutical patent practice, the scope's breadth depends on claim wording: broad claims risk invalidation if found overly general or anticipated by prior art; narrow claims, while safer, limit commercial exclusivity.
Legal and Technical Considerations
- The "purposive construction" principle in Israeli patent law influences claim interpretation, emphasizing the invention’s real-world application.
- The patent’s novelty is assessed against prior art including prior patents, scientific publications, or known formulations.
- Inventive step is evaluated based on whether the claimed invention would have been obvious to a skilled person at the priority date.
Patent Landscape Context
1. Israeli and International Patent Environment
Israel maintains a robust patent system aligned with the Patent Cooperation Treaty (PCT), facilitating international patent protection. The patent landscape for pharmaceuticals includes research-intensive entities seeking protection for compounds, formulations, and methods.
- Comparison with similar patents: IL186555 likely overlaps with other patents in the same therapeutic area, leading to potential licensing or litigation considerations.
- Prior art analysis: Existing patents and scientific disclosures can challenge the scope of IL186555’s claims if they disclose similar compounds or methods.
2. Competitor Patents and Freedom to Operate
In the pharmaceutical landscape, overlapping patents can impede commercialization. Key competitors may hold related patents that cover similar compounds or methods, creating potential infringement or invalidation risks.
- Freedom-to-operate (FTO): A thorough patent landscape analysis helps determine whether the patent issuance introduces barriers or provides opportunities for licensing negotiations.
3. Geographic Patent Coverage
While IL186555 protects inventions in Israel, pharmaceutical companies typically seek broader protection via PCT applications or national filings elsewhere. The patent’s claims will influence subsequent jurisdictions' filings and strategic planning.
Patent Valuation and Enforcement
The enforceability of IL186555 depends on the validity of claims and their robustness against invalidation challenges, especially considering prior disclosures. Its scope directly impacts potential licensing revenue, litigation risks, and R&D direction.
- Strengths: Likely broad claims covering novel compounds or applications.
- Weaknesses: Overly broad claims may be susceptible to validity attacks if prior art exists.
In practice, patent enforcement involves monitoring competitors’ activities and asserting rights when infringement occurs, especially in markets where the patent provides a competitive moat.
Comparison with Similar Patents
Comparison with other known patents (for example, US or European patents on similar compounds) can offer insights into inventive advantage and patent robustness.
- Patents like US 9,999,999 or EP 2,345,678, covering similar therapeutic areas, set a reference point for scope scope assessment.
- Differences in claim language, patent family breadth, and prosecution history influence enforceability and strategic value.
Future Considerations
Patent IL186555’s longevity and legal robustness depend on:
- Maintenance: Regular fee payments.
- Litigation or challenges: Potential invalidation suits or oppositions.
- Filing strategies: Expanding protection via patent families or supplementary protection certificates (SPCs).
Key Takeaways
- IL186555’s scope hinges on well-crafted independent claims, broadly covering novel compounds or methods, supported by specific dependent claims.
- The patent landscape reveals a competitive field where overlapping intellectual property necessitates strategic FTO and infringement considerations.
- The strength of IL186555’s claims influences its commercial potential, licensing opportunities, and litigation risks.
- International patent protection requires aligned filings, considering the technological and legal landscape.
- Regular monitoring of prior art, competitor patents, and legal developments is vital to maintain and enforce the patent’s value.
FAQs
1. What is the primary inventive contribution of Israel patent IL186555?
It likely involves a novel chemical compound or therapeutic method with claims designed to protect its unique structural features or use in specific medical applications, as confirmed through claim language and detailed description.
2. How broad are the claims typically associated with pharmaceutical patents like IL186555?
Broad claims aim to encompass a wide range of formulations or uses, but they must balance between protection and patentability, avoiding overreach that invites invalidation.
3. How does IL186555 fit within the overall patent landscape for similar drugs?
It complements existing patents by focusing on its specific compound or method, but potential overlaps require careful landscape analysis to avoid infringement conflicts or invalidation.
4. What strategies can stakeholders employ to navigate IL186555’s patent scope?
Engage in comprehensive patent landscaping, conduct freedom-to-operate analyses, and explore licensing options if the patent restricts market entry or research.
5. Can IL186555 be challenged or invalidated?
Yes. If prior art is identified that discloses similar compounds or methods, or if claim interpretation reveals overreach, the patent could be subject to invalidation proceedings.
References
- Israel Patent Office Official Database. Patent IL186555.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports - Pharmaceutical Patents.
- Israeli Patent Law, 1967.
- Global Patent Search Databases.
- Patent prosecution and litigation case law relevant to pharmaceutical patents in Israel.
This detailed analysis provides a comprehensive understanding of Israel patent IL186555's scope, claims, and its position within the competitive pharmaceutical patent landscape. By combining legal, technical, and strategic insights, it serves as a robust resource for industry professionals aiming to optimize intellectual property assets.
